News | January 09, 2012

Uninsured ED Patients Receive Fewer Imaging Scans Than Insured


January 9, 2012 – Uninsured patients, and those with Medicaid, receive far fewer imaging services than those with private insurance during emergency department (ED) visits, according to a study in the January issue of the Journal of the American College of Radiology.

The higher use of EDs by persons without health insurance is well documented. Previous studies have found that ED visits are more likely for the uninsured, persons below the 100 percent federal poverty level and those in poorer health.

“On average, Americans without health insurance receive fewer healthcare services than those with insurance. However, the specific types of services for which the uninsured face access and utilization deficits are not well understood,” said Kimberly E. Applegate, M.D., MS, lead author of the study.

The main database used for the study was the 2004 National Hospital Ambulatory Medical Care Survey. The survey contained two fields critical to the study: source of payment, and imaging services rendered and ordered by the referring ED doctor during the ED visit. Compared with comparable insured persons, non-elderly uninsured and Medicaid patients received fewer services in the ED. Similar results were found for the value of imaging services received.

“These results suggest that insurance status influences how much imaging and the intensity of imaging patients receive,” said Applegate. “Whether insured patients receive unnecessary imaging or uninsured and Medicaid patients receive too little imaging is not clear,” she said.

For more information: www.jacr.org.

 


Related Content

News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
News | Cardiovascular Clinical Studies

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
News | Cardiovascular Clinical Studies

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
News | Cardiovascular Clinical Studies

June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...

Home June 21, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital (BWH), a leading ...

Home June 20, 2024
Home
Subscribe Now